Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Post-approval studies (Phase 4)UnknownNCT05409547
What this trial is testing

A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF

Who this might be right for
Granulocyte Colony-stimulating FactorStem Cell Mobilization
Ning Huang 80
Not applicableEnded earlyNCT01135355
What this trial is testing

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Who this might be right for
Blood Stem Cell Transplant Failure
Stanford University 26
Large-scale testing (Phase 3)Looking for participantsNCT06514508
What this trial is testing

Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Guangzhou Gloria Biosciences Co., Ltd. 60
Large-scale testing (Phase 3)Ended earlyNCT00654433
What this trial is testing

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

Who this might be right for
Inherited Metabolic DiseasesLysosomal Storage DisordersPeroxisomal Storage Diseases+2 more
Aldagen 40
Testing effectiveness (Phase 2)Study completedNCT00046852
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
InfectionMultiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Large-scale testing (Phase 3)UnknownNCT00883714
What this trial is testing

Exercise During the Allogeneic Stem Cell Transplantation

Who this might be right for
FatigueAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany 60
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Testing effectiveness (Phase 2)Study completedNCT00165139
What this trial is testing

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Who this might be right for
NeuroblastomaEwings SarcomaNon-rhabdomyosarcoma Soft Tissue Sarcoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Large-scale testing (Phase 3)Study completedNCT01020175
What this trial is testing

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
European Society for Blood and Marrow Transplantation 350
Not applicableStudy completedNCT05147311
What this trial is testing

Positive Psychology Intervention In HSCT

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00146614
What this trial is testing

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancies
Dana-Farber Cancer Institute 105
Testing effectiveness (Phase 2)Study completedNCT00504634
What this trial is testing

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Large-scale testing (Phase 3)Study completedNCT01241708
What this trial is testing

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaAuto Stem Cell Transplant
Hackensack Meridian Health 148
Testing effectiveness (Phase 2)Study completedNCT00477750
What this trial is testing

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 33
Early research (Phase 1)Study completedNCT00477815
What this trial is testing

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01690143
What this trial is testing

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 45
Next Page